Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM PAR
-
Total 13F shares
-
916,014
-
Share change
-
-2,228
-
Total reported value
-
$6,320,000
-
Price per share
-
$6.90
-
Number of holders
-
20
-
Value change
-
-$15,169
-
Number of buys
-
6
-
Number of sells
-
5
Institutional Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q2 2016
As of 30 Jun 2016,
IMMUCELL CORP /DE/ - COM PAR (ICCC) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
916,014 shares.
The largest 10 holders included
NORTHPOINTE CAPITAL LLC, HEARTLAND ADVISORS INC, HealthInvest Partners AB, PERRITT CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, SHUFRO ROSE & CO LLC, MORGAN STANLEY, Essex Financial Services, Inc., VANGUARD GROUP INC, and Minerva Advisors LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.